◆Cellmat Therapeutics=Decision to proceed with a 1 billion KRW paid-in capital increase
◆Lotte Tour Development=Excluded from substantive review... Stock trading to resume on the 4th
◆Korea Kolmar=Acquisition of patents related to pressure dispersion components and pump containers
◆Korea Special Steel=Decision to proceed with a 27.8 billion KRW paid-in capital increase
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
